Goldline Pharmac

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1CLW01015
  • NSEID:
  • BSEID: 544759
INR
32.50
-0.5 (-1.52%)
BSENSE

Oct 09

BSE+NSE Vol: 3000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

32.5032.50

52 Week

0.000.00
Valuation
Technical
Day's Volume

CASH

3.0 k (-86.11%) Volume

Shareholding (May 2026)

FII

0.00%

Held by 0 FIIs

DII

20.29%

Held by 0 DIIs

Promoter

79.71%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 31 Cr ()

stock-summary
P/E

8.00

stock-summary
Industry P/E

36

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

2.22

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-20.73%
0%
-20.73%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Goldline Pharmac for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Closure of Trading Window

24-Sep-2026 | Source : BSE

Intimation of Closure of Trading window

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

02-Sep-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Amol Mujumdar

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

02-Sep-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Amol Mujumdar

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
3.65
Debt to EBITDA (avg)
1.32
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.33
Tax Ratio
23.56%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
20.29%
ROCE (avg)
29.36%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
36
Price to Book Value
2.22
EV to EBIT
6.01
EV to EBITDA
5.80
EV to Capital Employed
1.76
EV to Sales
1.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
29.36%
ROE (Latest)
28.91%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Sideways
KST
Dow Theory
Bearish
OBV
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : May 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Swapan Premprakash Khandelwal (39.85%)

Highest Public shareholder

Sumit Bilgaiyan (7.03%)

Individual Investors Holdings

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Goldline Pharmac"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Goldline Pharmac"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Goldline Pharmac"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Goldline Pharmac"
  }
]
stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."